Physician profile
Mitchell C Latter
NPI 1255411625
$8,560.25
in general payments reported to CMS, 2019-2025
16 companies · $1,805 in 2025
The $1,805 reported for 2025 was more than what 87% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $997 · 2020: $506 · 2021: $728 · 2022: $1,078 · 2023: $781 · 2024: $2,665 · 2025: $1,805.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,714 · Travel and Lodging: $1,519 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,713.59 |
| Travel and Lodging | $1,518.94 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $3,003.78 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $2,069.39 | 2019-2025 | Cequa, Xelpros |
| Novartis Pharmaceuticals Corporation | $716.33 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $608.13 | 2023-2025 | Vyzulta, Miebo, Xiidra |
| Allergan, INC. | $402.83 | 2020-2022 | |
| Dompe US, INC. | $386.76 | 2022-2025 | Oxervate |
| Oyster Point Pharma, INC. | $341.49 | 2024-2025 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $205.77 | 2019-2021 | |
| Alcon Vision LLC | $184.29 | 2023-2025 | Rocklatan, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $145.75 | 2025 | Xdemvy |
| Rxsight INC | $135.56 | 2025 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Thea Pharma INC. | $110.12 | 2023-2025 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $105.04 | 2019-2022 | |
| Abbvie INC. | $59.35 | 2022-2023 | |
| Harrow Eye, LLC | $46.86 | 2025 | Vevye |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $38.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Latter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.